Bevacizumab with, without irinotecan improved response, survival in recurrent glioblastoma | HemOncToday
Links shared publicly online about this topic.
- 1,773total visits
Bevacizumab with, without irinotecan improved response, survival in recurrent glioblastoma | HemOncToday
Bevacizumab alone or in combination with irinotecan improved response rates, PFS and OS compared with that typically seen in patients with recur
View full resource at hemonctoday.com
Tags: Colorectal Cancer Medication, Avastin, Camptosar
Most Recently Shared on September 4, 2009 at 2:19 pm By:
Presented at #ASCO 08 http://ow.ly/o3Qb Now in JCO, bevacizumab with, without irinotecan improved survival in glioblastoma http://ow.ly/o3Qq
Advertisement
